000 | 01677 a2200469 4500 | ||
---|---|---|---|
005 | 20250511200422.0 | ||
264 | 0 | _c19910731 | |
008 | 199107s 0 0 eng d | ||
022 | _a0091-3057 | ||
024 | 7 |
_a10.1016/0091-3057(91)90289-e _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSteele, T D | |
245 | 0 | 0 |
_aAssessment of the role of alpha-methylepinine in the neurotoxicity of MDMA. _h[electronic resource] |
260 |
_bPharmacology, biochemistry, and behavior _cFeb 1991 |
||
300 |
_a345-51 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_a3,4-Methylenedioxyamphetamine _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBiogenic Amines _xmetabolism |
650 | 0 | 4 |
_aBrain Chemistry _xdrug effects |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
650 | 0 | 4 |
_aDeoxyepinephrine _xadministration & dosage |
650 | 0 | 4 | _aElectrochemistry |
650 | 0 | 4 | _aInjections, Intraventricular |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMicrosomes, Liver _xdrug effects |
650 | 0 | 4 | _aN-Methyl-3,4-methylenedioxyamphetamine |
650 | 0 | 4 |
_aNervous System Diseases _xchemically induced |
650 | 0 | 4 |
_aPhenobarbital _xpharmacology |
650 | 0 | 4 |
_aProadifen _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Strains |
650 | 0 | 4 | _aSpecies Specificity |
700 | 1 | _aBrewster, W K | |
700 | 1 | _aJohnson, M P | |
700 | 1 | _aNichols, D E | |
700 | 1 | _aYim, G K | |
773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 38 _gno. 2 _gp. 345-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0091-3057(91)90289-e _zAvailable from publisher's website |
999 |
_c1682586 _d1682586 |